Product description

Etoposide or VP-16 is a cytotoxic anticancer drug which belongs to thetopoisomerase inhibitor drug class. It is used as a form of chemotherapy for cancers such as Kaposi’s sarcoma, Ewing's sarcoma, lung cancer, testicular cancer, lymphoma, nonlymphocytic leukemia, and glioblastoma multiforme. It is often given in combination with other drugs (such as bleomycin in treating testicular cancer). It is also sometimes used in a conditioning regimen prior to a bone marrow or blood stem cell transplant.

It is approved by NMPA.
It is approved by US-FDA and EDQM, and US-DMF and EDMF are available.
Stability study zone IVB data are available.
Read more


CAS Registry Number 33419-42-0
Categories APIs (Active Pharmaceutical Ingredients)
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Supplied from China

More products from Jiangsu Hengrui Medicine Co., Ltd.

View all our products (106)

Products from other suppliers